Plassche Douglas

Track

Insider profile

Plassche Douglas's trades of Elite Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
287.48
Quantity 76,121 +19.4%
Value US$2,606,307
Transaction date
Proposed sale
Price
52.22
Quantity 74,884
Value US$4,500,875
Transaction date
Sale
Price
216.34
Quantity 35,295 -33.8%
Value US$4,246,902
Transaction date
Proposed sale
Price
0.61
Quantity 500,000
Value US$303,000
Transaction date
Sale
Price
0.51
Quantity 333,932 -100.0%
Value US$170,305
Transaction date
Sale
Price
0.49
Quantity 800,000 -70.6%
Value US$392,000
Transaction date
Proposed sale
Price
0.60
Quantity 1,133,932
Value US$680,359
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-03 2025-10-02
S Sale
76,121 +19.4%
287.48
US$2,606,307 		76,121 +19.4% 287.48 US$2,606,307
2025-08-22 2025-08-22
PrS Proposed sale
74,884
52.22
US$4,500,875 		74,884 52.22 US$4,500,875
2025-07-10 2025-07-08
S Sale
35,295 -33.8%
216.34
US$4,246,902 		35,295 -33.8% 216.34 US$4,246,902
2025-07-08 2025-07-08
PrS Proposed sale
500,000
0.61
US$303,000 		500,000 0.61 US$303,000
2024-10-28 2024-10-24
S Sale
333,932 -100.0%
0.51
US$170,305 		333,932 -100.0% 0.51 US$170,305
2024-10-28 2024-10-23
S Sale
800,000 -70.6%
0.49
US$392,000 		800,000 -70.6% 0.49 US$392,000
2024-10-23 2024-10-23
PrS Proposed sale
1,133,932
0.60
US$680,359 		1,133,932 0.60 US$680,359